Gilead ordered to pay $200 million in damages to Merck & Co | Pharmaceutical | The Pharmaletter | The Pharmaletter

A federal jury in California has ordered Gilead Sciences (Nasdaq: GILD) to pay $200 million in damages to Merck & Co (NYSE: MRK) and its partner ...